FIELD: medicine. n SUBSTANCE: method involves administering pyrimidine nucleotide precursors at a daily dose of 0.05-0.3 g/kg of body weight. The method is applicable under condition that cytotoxic chemotherapy agent does not belong to pyrimidine nucleoside analogs. n EFFECT: enhanced effectiveness in eliminating mitochondrial respiration chain dysfunction. n 2 cl